It is known from previous studies that OPN could have cell survival effects in neurons both in vitro and in vivo.[17, 85, 131] On the other hand, osteopontin receptor CD44 deficiency has been shown to have beneficial effects in cerebral ischemia [114] and in glioma [92]. The gene discussed is CD44; the disease is central nervous system cancer.